Drugs - Real World Outcomes View Homepage


Ontology type: schema:Periodical      Open Access: True


Journal Info

START YEAR

2014

PUBLISHER

Springer International Publishing

LANGUAGE

en

HOMEPAGE

https://link.springer.com/journal/40801

Recent publications latest 20 shown

  • 2021-11-19 Pregnancy Loss Signal from Prostaglandin Eye Drop Use in Pregnancy: A Disproportionality Analysis Using Japanese and US Spontaneous Reporting Databases
  • 2021-11-15 Acknowledgement to Referees
  • 2021-11-15 Real-World Use and Outcomes of Oral Antiplatelets Among Patients with Acute Coronary Syndrome: A Retrospective Cohort Study
  • 2021-10-30 Falls and Fractures in Patients with Parkinson’s Disease-Related Psychosis Treated with Pimavanserin vs Atypical Antipsychotics: A Cohort Study
  • 2021-10-06 Adverse Drug Reactions in Japanese Patients with End-Stage Heart Failure Receiving Continuous Morphine Infusion: A Single-Center Retrospective Cohort Study
  • 2021-09-29 Unintentional Medication Discrepancies at Admission Among Elderly Inpatients with Chronic Medical Conditions in Vietnam: A Single-Centre Observational Study
  • 2021-09-27 Anti-Epileptic Medication Exposure Influences Functional Status in New Zealand Stroke Patients: A Retrospective Population-Level Study
  • 2021-09-17 European and US Real-World Treatment Patterns in Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Medical Record Review
  • 2021-09-16 Reporting Rates of Opioid-Related Adverse Events Since 1965 in Canada: A Descriptive Retrospective Study
  • 2021-09-15 Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database
  • 2021-09-12 Human Papillomavirus Vaccination and Premature Ovarian Failure: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System
  • 2021-09-12 Treatment Patterns in Patients with Locally Advanced or Metastatic Non-Small-Cell Lung Cancer Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: Analysis of US Insurance Claims Databases
  • 2021-09-03 Sodium-Glucose Cotransporter-2 Inhibitor Use is Associated with a Reduced Risk of Heart Failure Hospitalization in Patients with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes Mellitus: A Real-World Study on a Diverse Urban Population
  • 2021-08-29 Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study
  • 2021-08-28 Comparison Between Health Insurance Claims and Electronic Health Records (EHRs) for Metastatic Non-small-cell Lung Cancer (NSCLC) Patient Characteristics and Treatment Patterns: A Retrospective Cohort Study
  • 2021-08-25 Effectiveness and Tolerability of Fondaparinux vs Enoxaparin in a Population of Indian Patients with Symptomatic Deep Vein Thrombosis: A Retrospective Real-World Study
  • 2021-08-19 Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study
  • 2021-07-28 Safety of Anthroposophic Medicinal Products: An Analysis of Adverse Drug Reactions from German Pharmacovigilance Databases
  • 2021-07-17 Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
  • 2021-06-25 Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Real Life: One-Year Clinical and Economic Outcomes
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "0.9079999923706055", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "0.4300000071525574", 
            "type": "Rating"
          }
        ], 
        "description": "

    Drugs - Real World Outcomes targets research involving the use of real-world data to evaluate health outcomes and inform healthcare decision-making, with a particular focus on healthcare-related 'big data'. Drugs - Real World Outcomes has a broad scope, encompassing studies investigating drug utilisation, patterns of prescribing, pharmacovigilance, treatment guideline adherence, benefit-risk assessments, comparative effectiveness and economic analyses.

    \n\n

    Drugs - Real World Outcomes offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review (single-blind) is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.
    \n
    \nManuscripts submitted to the journal for publication will be subject to an article processing charge (APC) upon acceptance. Please click on the ‘Fees and funding’ link for details of the current APC and open access funding and support services. Adis Open Access enables you to make your journal article freely available to anyone, in exchange for payment of the APC. This option allows you, the author, to retain the copyright of the article according to the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC) License, which does not permit commercial re-use of the article.

    \n", "editor": [ { "familyName": "Peters", "givenName": "Dene", "type": "Person" } ], "id": "sg:journal.1051855", "inLanguage": [ "en" ], "isAccessibleForFree": true, "issn": [ "2199-1154", "2198-9788" ], "license": "Fully Open Access", "name": "Drugs - Real World Outcomes", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "51855" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "2015243440" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "101658456" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "489866" ] }, { "name": "era_ids_id", "type": "PropertyValue", "value": [ "210383" ] } ], "publisher": { "name": "Springer International Publishing", "type": "Organization" }, "publisherImprint": "Adis", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1051855" ], "sdDataset": "journals", "sdDatePublished": "2021-12-01T20:17", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/journal/journal_0.jsonl", "startYear": "2014", "type": "Periodical", "url": "https://link.springer.com/journal/40801" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1051855'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1051855'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1051855'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1051855'


     

    This table displays all metadata directly associated to this object as RDF triples.

    60 TRIPLES      20 PREDICATES      27 URIs      23 LITERALS      10 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1051855 schema:contentRating N3eaf8ff0569d41b8977d426773b7061e
    2 N8ec1c6c0c8ff48bc9d51d014e469ae3f
    3 schema:description <p><em>Drugs - Real World Outcomes</em> targets research involving the use of real-world data to evaluate health outcomes and inform healthcare decision-making, with a particular focus on healthcare-related &#39;big data&#39;. <em>Drugs - Real World Outcomes</em> has a broad scope, encompassing studies investigating drug utilisation, patterns of prescribing, pharmacovigilance, treatment guideline adherence, benefit-risk assessments, comparative effectiveness and economic analyses.</p> <p><em>Drugs - Real World Outcomes</em> offers a range of additional features designed to increase the visibility, readership and educational value of the journal&rsquo;s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review (single-blind)&nbsp;is conducted using Editorial Manager&reg;, supported by a database of international experts. This database is shared with other Adis journals.<br /> <br /> Manuscripts submitted to the journal for publication will be subject to an article processing charge (APC) upon acceptance.&nbsp;Please click on the &lsquo;Fees and funding&rsquo; link for details of the current APC and open access funding and support services. Adis Open Access enables you to make your journal article freely available to anyone, in exchange for payment of the APC. This option allows you, the author, to retain the copyright of the article according to the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC) License, which does not permit commercial re-use of the article.</p>
    4 schema:editor N147c2d25f5a744d8a73d49446f812454
    5 schema:inLanguage en
    6 schema:isAccessibleForFree true
    7 schema:issn 2198-9788
    8 2199-1154
    9 schema:license Fully Open Access
    10 schema:name Drugs - Real World Outcomes
    11 schema:productId N16a8ee476b3d461eb8a5e254d05fc5ff
    12 N1dbf016357c2429ab71f308ee947c8d7
    13 N359fd7deaba54559b0694bd32817070c
    14 N54924627b9e04602a6dded3b259bded8
    15 N666ffa83d109459598e5a9b10702513e
    16 schema:publisher N47004497effe409b864cd91f3f075ad8
    17 schema:publisherImprint Adis
    18 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1051855
    19 schema:sdDatePublished 2021-12-01T20:17
    20 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    21 schema:sdPublisher N58ac50cb25a7409d95f26632b8d5a8f3
    22 schema:startYear 2014
    23 schema:url https://link.springer.com/journal/40801
    24 sgo:license sg:explorer/license/
    25 sgo:sdDataset journals
    26 rdf:type schema:Periodical
    27 N147c2d25f5a744d8a73d49446f812454 rdf:first Nb821b223cb1c4be1b433229a1f88962d
    28 rdf:rest rdf:nil
    29 N16a8ee476b3d461eb8a5e254d05fc5ff schema:name era_ids_id
    30 schema:value 210383
    31 rdf:type schema:PropertyValue
    32 N1dbf016357c2429ab71f308ee947c8d7 schema:name nsd_ids_id
    33 schema:value 489866
    34 rdf:type schema:PropertyValue
    35 N359fd7deaba54559b0694bd32817070c schema:name dimensions_id
    36 schema:value 51855
    37 rdf:type schema:PropertyValue
    38 N3eaf8ff0569d41b8977d426773b7061e schema:author Nd560f757852743fb96e25a5f0e167189
    39 schema:ratingValue 0.9079999923706055
    40 rdf:type schema:Rating
    41 N47004497effe409b864cd91f3f075ad8 schema:name Springer International Publishing
    42 rdf:type schema:Organization
    43 N54924627b9e04602a6dded3b259bded8 schema:name lccn_id
    44 schema:value 2015243440
    45 rdf:type schema:PropertyValue
    46 N58ac50cb25a7409d95f26632b8d5a8f3 schema:name Springer Nature - SN SciGraph project
    47 rdf:type schema:Organization
    48 N666ffa83d109459598e5a9b10702513e schema:name nlm_unique_id
    49 schema:value 101658456
    50 rdf:type schema:PropertyValue
    51 N8ec1c6c0c8ff48bc9d51d014e469ae3f schema:author Nd9bb70f7556e4150a2404c2801309bcb
    52 schema:ratingValue 0.4300000071525574
    53 rdf:type schema:Rating
    54 Nb821b223cb1c4be1b433229a1f88962d schema:familyName Peters
    55 schema:givenName Dene
    56 rdf:type schema:Person
    57 Nd560f757852743fb96e25a5f0e167189 rdf:first snip
    58 rdf:rest rdf:nil
    59 Nd9bb70f7556e4150a2404c2801309bcb rdf:first sjr
    60 rdf:rest rdf:nil
     




    Preview window. Press ESC to close (or click here)


    ...